Mylan Laboratories Limited

Form 483 issued May 15, 2026 · Sinnar, India

Inspection
May 4 – May 15, 2026
Observations
1
Pages
27

In short: On May 15, 2026, FDA issued a Form 483 with 1 observation to Mylan Laboratories Limited in Sinnar, India after an inspection that ran May 4 – May 15, 2026. The investigators were Pratik S. Upadhyay and Unnee Ranjan. Most observations concern quality system; the most-cited regulation is 21 CFR 211.22 (responsibilities of quality control unit).

At a glance

1 of 1 observations on this 483 concern quality system.

Quality system1

Most cited: 21 CFR 211.22 (1×) · 211.188 (1×)

What FDA observed

Preview: the opening words of each observation

Dashed: section inferred by FDA Intel and checked against the regulation text

  1. 01

    The responsibilities and procedures applicable to the quality control unit…

The full 483

Plus the full detail behind each one, exactly as FDA wrote it.

Get the full 483

This inspection in context

Questions about this 483

What did FDA find at Mylan Laboratories Limited?

FDA listed 1 observation on this Form 483, mostly about quality system. The most-cited regulation is 21 CFR 211.22 (responsibilities of quality control unit). The opening words of each observation are shown on this page.

Who inspected Mylan Laboratories Limited?

Pratik S. Upadhyay and Unnee Ranjan are named on this Form 483, for the inspection of May 4 – May 15, 2026. Each investigator has a profile showing what they cite most.

When was Mylan Laboratories Limited inspected by FDA?

The inspection ran May 4 – May 15, 2026, and the Form 483 is dated May 15, 2026.

How do I get the full Form 483 for Mylan Laboratories Limited?

Download the original PDF from FDA Intel for $99, with no subscription. Your first Form 483 or letter is on us. You also get an invoice PDF with the order.

$99Get it free